Mr Stephen Quinn


MRI-guided Focused Ultrasound is a non-invasive treatment for symptomatic uterine fibroids.

It offers many advantages, including the following:

  • Recovery time is 1-2 days
  • Works by using high intensity focused ultrasound to cause thermal destruction of uterine fibroids through coagulative necrosis
  • No infective morbidity or post-procedural pain is associated with this treatment
  • No instances of adhesions or ovarian failure have been reported
  • Tissue damage is confined to the fibroid and does not affect the normal myometrium, the endometrium or the serosa
  • MRgFUS is considered fertility-sparing, with a lower risk of hysterectomy than other procedures, and growing evidence of successful pregnancies

In summary, this treatment:

  • Alleviates the painful and often life-debilitating symptoms of Uterine Fibroids, which include menstrual flooding
  • is non-invasive, unlike other alternatives
  • is carried out in an outpatient setting
  • recovery time is 1-2 days
  • is funded on a case-by case basis by PCTs, routinely by Aviva, and regularly (on a case by case basis) by Bupa, and other insurers similarly